Form 4 Tracker
Mitchell Chan

Director · 2 filings · Latest: May 6, 2026

Avalo Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AVTX
Mitchell ChanDirectorMay 6, 2026
Sale
$22.883,167$72.5K3,166
AVTX
MITCHELL CHANMay 6, 2026
Proposed Sale
$16.263,167$51.5K
AVTX
Mitchell ChanDirectorMar 28, 2026
Option Exercise
3,1666,333